About Movember
Financials
Programs We Fund
Contact Us
Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is firmly committed to curing prostate cancer and is the leading philanthropic organization accelerating research globally. Since 1993, PCF’s unique strategies for identifying and investing in the most promising research programs have generated life-saving results. The Prostate Cancer Foundation channels resources to the world’s top scientists and institutions, cutting red tape and encouraging collaboration to speed breakthroughs. Funding more than $475 million, PCF has supported more than 1,600 research programs at nearly 200 research centers in 15 countries.
For more information on the research the PCF is funding visit: www.pcf.org
Prostate Cancer Foundation
1250 Fourth Street
Santa Monica, CA 90401
1.800.757.CURE (2873)
Watch the video of Dr. Jonathan Simons as he explains how Movember is making an impact on prostate cancer research.
Examples of Movember Funded Programs
Program 1: Whole Genome Sequencing
As a result of the Movember community, for the first time scientists have been able to construct a complete genetic map of prostate cancer. This means that patients will eventually be able to work with their doctors to map the individual genetic alterations of their prostate cancer to determine the specific treatment needed for them. The result will be less men dying from prostate cancer, more effective treatment with less side effects, and it will spare some men from unnecessary treatments, eliminating an estimated $1.5 billion spent each year in over-treatment.
It is a truly historic development in the fight against prostate cancer and will expand the understanding of how the disease works, leading to improved and more personalized treatment.
The Prostate Cancer Foundation, the Broad Institute of Harvard, the Massachusetts Institute of Technology in Cambridge, Massachusetts, and the Dana-Farber Cancer Institute in Boston collaborated on this break-through research project.
Program 2: 27+ Types of Prostate Cancer
Arul Chinnaiyan, MD, PhD, and his colleagues at the University of Michigan has, through the PCF, completed a research program identifying 27+ different types of prostate cancer. This discovery will soon answer the agonizing question facing men with prostate cancer: does their cancer need immediate treatment or can it be left alone?
By identifying which type of prostate cancer a man has, the PCF will soon enable physicians and clinicians to distinguish between aggressive and non-aggressive prostate cancers and prescribe targeted treatments or proactive surveillance for patients. This same study found that rare rearrangements of a certain gene may be associated with more aggressive prostate cancers and tumor progression. This is the first time this type of gene has been found in prostate cancer. These discoveries will eventually help scientists identify potential new drug targets and move us closer to the goal of curing prostate cancer with less over-treatment.
“Movember has initiated a growing international dialog on prostate cancer and men’s health and is an invaluable partner in energizing the global research enterprise for prostate cancer. Here in the U.S., unrestricted funding from Movember is helping the Prostate Cancer Foundation accelerate the world’s most promising research, enabling game-changing projects from whole genome sequencing and the development of innovative therapies. These will help men with advanced prostate cancer live longer, more productive lives than ever before.” - Dr. Jonathan Simons, CEO and President of the Prostate Cancer Foundation
Read up on all the latest Moustache Season news and highlights.
Grow, show and connect with your fellow Mo's.
Check out the Mo fundraising totals from around the world.
Gear up with some Movember merchandise.
Your health, your responsibility. Find out more.
© 2011 Movember Foundation. All rights reserved.